Giant Biogene Holding Co., Ltd. (HKG:2367)

Market Cap	86.54B
Revenue (ttm)	5.89B
Net Income (ttm)	2.19B
Shares Out	1.06B
EPS (ttm)	2.19
PE Ratio	37.29
Forward PE	30.34
Dividend	1.29 (1.53%)
Ex-Dividend Date	Jun 17, 2025

Volume	4,603,050
Average Volume	5,808,822
Open	81.75
Previous Close	81.75
Day's Range	80.10 - 82.05
52-Week Range	35.00 - 87.10
Beta	0.84
RSI	56.66
Earnings Date	May 19, 2025

About Giant Biogene Holding

Giant Biogene Holding Co., Ltd., an investment holding company, designs, develops, and manufactures skin treatment products with recombinant collagen in the People’s Republic of China. It also develops and manufactures rare ginsenosides technology-based functional food products; and offers medical devices. The company offers its functional skincare products, medical dressings, and functional food products primarily under the Comfy, Collgene, Ke Yu, and SKIGIN brands. Giant Biogene Holding Co., Ltd. was founded in 2000 and is headquartered in Xi...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 2000
• Employees: 1,758
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2367

Financial Performance

In 2024, Giant Biogene Holding's revenue was 5.54 billion, an increase of 57.17% compared to the previous year's 3.52 billion. Earnings were 2.06 billion, an increase of 42.06%.

Financial numbers in CNY